tread.fi | $3,500,000 | (Jul 12, 2024)
Medal.tv | $13,000,000 | (Jul 12, 2024)
Spotlight Medical | $6,760,573 | (Jul 12, 2024)
Certified by Founder
Lodge
Myricx Bio
start up
United Kingdom
- London
- 09/07/2024
- Series A
- $115,246,800
We are a UK biotech company focused on the discovery and development of a completely novel class of selective cytotoxic payloads for antibody drug conjugates (ADCs), based on inhibitors of N-myristoyltransferases (NMT) for the treatment of cancer.
- Industry Biotechnology Research
- Website https://myricxbio.com/
- LinkedIn https://www.linkedin.com/company/myricx-pharma-ltd/
Element Biosciences | $277,000,000 | (Jul 12, 2024)
Byway | $6,463,500 | (Jul 12, 2024)
lemon.markets | $12,000,000 | (Jul 12, 2024)
Arkion (formerly Skyqraft) | $4,000,000 | (Jul 12, 2024)
Exein | $16,359,075 | (Jul 12, 2024)
Switchee | $6,452,000 | (Jul 12, 2024)
Soda | $14,000,000 | (Jul 12, 2024)
ProofPilot | Undisclosed Amount | (Jul 12, 2024)
Earned Wealth | $200,000,000 | (Jul 12, 2024)